Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04245085
Title ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma (ABC-lung)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Thoracic Oncology Platform
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP | DEU

Facility Status City State Zip Country Details
LungenClinic Grosshansdorf Großhansdorf Germany Details
Asklepios Fachkliniken München-Gauting München Germany Details
National Cancer Center Goyang Korea, Republic of Details
Severance Hospital, Yonsei University Health System Seoul Korea, Republic of Details
National University Hospital Singapore Singapore Details
ICO - Hospital Universitari Germans Trias i Pujol Badalona Spain Details
Hospital De La Santa Creu I Sant Pau Barcelona Spain Details
Vall d'Hebron University Hospital Barcelona Spain Details
OSI Bilbao Basurto Bilbao Spain Details
Complejo Hospitalario de Jaén Jaén Spain Details
Hospital Teresa Herrera La Coruña Spain Details
Hospital Universitario Insular Gran Canaria Las Palmas De Gran Canaria Spain Details
Hospital Puerta de Hierro Madrid Spain Details
Hospital Universitario Fundacion Jimenez Díaz Madrid Spain Details
Hospital General de Valencia Valencia Spain Details
Hôpitaux Universitaires de Genève Geneva Switzerland Details
Kantonsspital St. Gallen St. Gallen Switzerland Details
UniversitätsSpital Zürich Zürich Switzerland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field